The effect of the small molecule inhibitors JNJ-165 and PHA-680632 on AURKA nuclear translocation in breast cancer cells was examined by immunofluorescence assays, which showed that the two inhibitors promoted the cytoplasmic accumulation of AURKA in MCF-7 cells (Fig. 5A). Here, AURKA is linked to breast cancer.